ACRIVON THERAPEUTICS, INC. COMMON STOCK
ACRV -0.86
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 1.9M |
| Cost of Revenue | 0.1M |
| Gross Profit | 1.7M |
| Operating Expense | 20.9M |
| Operating I/L | -21.1M |
| Other Income/Expense | 1.8M |
| Interest Income | 0.0M |
| Pretax | -19.3M |
| Income Tax Expense | 1.8M |
| Net Income/Loss | -19.3M |
Acrivon Therapeutics, Inc. Common Stock
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
